| Dr Brian J Linder, M D | |
|
539 S. Main St., Findlay, OH 45840 | |
| (419) 421-2062 | |
| (419) 421-4559 |
| Full Name | Dr Brian J Linder |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 539 S. Main St., Findlay, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962436477 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | 35.056782 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian J Linder, M D 24290 Sun Air Blvd, Perrysburg, OH 43551-9484 Ph: () - | Dr Brian J Linder, M D 539 S. Main St., Findlay, OH 45840 Ph: (419) 421-2062 |
News Archive
By analyzing medical records gathered over three decades on more than 11,000 Americans participating in a federally funded study, researchers at Johns Hopkins Medicine say they have more evidence that driving diastolic blood pressure too low is associated with damage to heart tissue.
Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
According to a new study on cases of scarlet fever and other Streptococcus A infections in England and Wales, the recent rise in cases is due to a newly identified strain. This accounted for the great increase in the number of cases of scarlet fever that occurred in 2014. The last such outbreak was way back in the 1960s.
A bedside electronic device that measures eye movements can successfully determine whether the cause of severe, continuous, disabling dizziness is a stroke or something benign, according to results of a small study led by Johns Hopkins Medicine researchers.
› Verified 9 days ago
Allison Christina Kleinhans, MAT,AT,ATC Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 N Main St, Findlay, OH 45840 Phone: 724-825-5291 | |
Dr. Scott David Leslie, M.D., M.P.H. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 3949 N Main St, Suite D, Findlay, OH 45840 Phone: 419-425-5121 Fax: 419-425-5738 |